Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
89 participants
INTERVENTIONAL
2021-05-04
2025-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Stress Response in Opioid Use Disorder
NCT03616379
A Mobile Executive Functioning Intervention for Momentary Craving in Opioid Use Disorders
NCT05086835
Clinical Trial of Integrated Treatment for Pain and Opioid Dependence
NCT00634803
Cognitive-Behavioral Therapy for Pain and Opioid Dependence in Methadone Maintenance Treatment
NCT01334580
Memantine-enhanced Buprenorphine Treatment for Opioid-dependent Young Adults
NCT01052662
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pain De-Catastrophizing
Brief behavioral education on how to modify the interpretation of pain.
Pain De-Catastrophizing
Experimenter-administered education and skill practice.
Pain Education
Brief behavioral education on pain.
Pain Education
Experimenter-administered education.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pain De-Catastrophizing
Experimenter-administered education and skill practice.
Pain Education
Experimenter-administered education.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* diagnosis of opioid use disorder
* chronic pain
* ability to read and provide informed consent
Exclusion Criteria
* current opioid withdrawal
* currently receiving opioid analgesic medication for pain
* recent history of myocardial infarction or other serious cardiovascular condition
* current peripheral neuropathy, active vasculitis or severe peripheral vascular disease
* systematic inflammatory or autoimmune disorder
* admitted to current treatment episode on an involuntary status
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
Mclean Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
McHugh, R. Kathryn
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rebecca K McHugh, PhD
Role: PRINCIPAL_INVESTIGATOR
Mclean Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
McLean Hospital
Belmont, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019P002720
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.